Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00394758 · ClinicalTrials.gov registry record · Phase 3
A Randomized Trial of Surgical Treatments for Vulvar and Vaginal Dysplasia
A Phase 3 study of Vulvar Dysplasia and Vaginal Dysplasia, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT00394758: Completed Phase 3 study of Vulvar Dysplasia and Vaginal Dysplasia, sponsored by University Hospitals Cleveland Medical Center.
NCT00394758 is a Phase 3 study of Vulvar Dysplasia and Vaginal Dysplasia that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 150 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00394758, a Phase 3 study of Vulvar Dysplasia and Vaginal Dysplasia, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
1. To compare the recurrence rate between the use of laser vaporization and ultrasonic surgical aspiration in the treatment of vulvar and vaginal dysplasias 2. To compare healing related complications, post-operative pain, and scarring between the two procedures.
Conditions Studied
Interventions
- PROCEDURE CO2 laser surgery
- PROCEDURE ultrasonic surgical aspiration
Study Locations (1)
Ohio
- University Hospitals of Cleveland - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2000-01-01 |
| Est. Completion | 2005-12-31 |
| Phase | Phase 3 |
What the finished NCT00394758 record still lists
NCT00394758 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (81% lower).
The record links to 2 conditions, with Vulvar Dysplasia appearing as the primary indexed condition, and to 2 interventions - of which CO2 laser surgery is the first listed.
NCT00394758 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT00394758 about?
NCT00394758 is a clinical study titled "A Randomized Trial of Surgical Treatments for Vulvar and Vaginal Dysplasia". 1. To compare the recurrence rate between the use of laser vaporization and ultrasonic surgical aspiration in the treatment of vulvar and vaginal dysplasias 2. To compare healing related complications, post-operative pain, and scarring between the two procedures.
What is the current status of trial NCT00394758?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 150 participants. The study started on 2000-01-01. Estimated completion is 2005-12-31.
What conditions does trial NCT00394758 study?
This clinical trial studies the following conditions: Vulvar Dysplasia, Vaginal Dysplasia.
What interventions are being tested in trial NCT00394758?
The interventions under investigation include: CO2 laser surgery (PROCEDURE), ultrasonic surgical aspiration (PROCEDURE).
Who is sponsoring clinical trial NCT00394758?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00394758 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00394758's enrollment target sits among peer trials
150 1519th of 2000 higher than 455 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI